2023 - Research.com Microbiology in Australia Leader Award
His scientific interests lie mostly in Immunology, Quinolinic acid, Dementia, Acquired immunodeficiency syndrome and Kynurenine pathway. His work carried out in the field of Immunology brings together such families of science as Cerebrospinal fluid and Virology. Bruce J. Brew has researched Quinolinic acid in several fields, including Neurotoxicity, Pathogenesis, Astrocyte, Pharmacology and Kynurenine.
His Dementia study integrates concerns from other disciplines, such as Viral disease, Opportunistic infection, HIV-associated neurocognitive disorder and Immunopathology. The Acquired immunodeficiency syndrome study combines topics in areas such as Neurocognitive, Internal medicine, Incidence and Psychiatry. His Kynurenine pathway research incorporates themes from Kynurenic acid, Cell biology, Microglia and Indoleamine 2,3-dioxygenase.
His primary areas of study are Immunology, Internal medicine, Neurocognitive, Acquired immunodeficiency syndrome and Dementia. His Immunology study combines topics from a wide range of disciplines, such as Quinolinic acid, Cerebrospinal fluid and Central nervous system. As a part of the same scientific family, he mostly works in the field of Quinolinic acid, focusing on Kynurenic acid and, on occasion, Kynurenine pathway.
His work deals with themes such as Gastroenterology, Endocrinology, Viral load and Oncology, which intersect with Internal medicine. As part of one scientific family, Bruce J. Brew deals mainly with the area of Neurocognitive, narrowing it down to issues related to the Disease, and often Intensive care medicine. Bruce J. Brew has included themes like Mental health, Neurology, Cognition and Pediatrics in his Acquired immunodeficiency syndrome study.
Bruce J. Brew mainly focuses on Neurocognitive, Internal medicine, Cognition, Immunology and HIV-associated neurocognitive disorder. He combines subjects such as Dementia, Disease, Gerontology and Neuropsychology with his study of Neurocognitive. His Acquired immunodeficiency syndrome research extends to the thematically linked field of Cognition.
In general Immunology, his work in BCL11B is often linked to Microvesicles linking many areas of study. His study looks at the relationship between HIV-associated neurocognitive disorder and fields such as Psychiatry, as well as how they intersect with chemical problems. His research investigates the connection with Quinolinic acid and areas like Excitotoxicity which intersect with concerns in Kynurenine pathway.
Bruce J. Brew mostly deals with Internal medicine, Neurocognitive, Immunology, Randomized controlled trial and HIV-associated neurocognitive disorder. His work in the fields of Internal medicine, such as Meta-analysis and Chronic meningitis, overlaps with other areas such as Metagenomics and DNA sequencing. His Neurocognitive research is multidisciplinary, incorporating elements of Clinical trial, Neuropsychological test, Neuropsychology, Test performance and Pediatrics.
His Immunology research is multidisciplinary, incorporating perspectives in Neuropathic pain, Asymptomatic and Nerve growth factor. His HIV-associated neurocognitive disorder research includes elements of Csf biomarkers, Cellular energy and BCL11B. His research in Cerebrospinal fluid tackles topics such as Tau protein which are related to areas like Kynurenine pathway and Kynurenine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Updated research nosology for HIV-associated neurocognitive disorders
A. Antinori;G. Arendt;J. T. Becker;B. J. Brew.
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex
Richard W. Price;Bruce Brew;John Sidtis;Marc Rosenblum.
The AIDS Dementia Complex
Richard W. Price;Bruce J. Brew.
The Journal of Infectious Diseases (1988)
Neurological complications of HIV infection
Justin C McArthur;Bruce J Brew;Avi Nath.
Lancet Neurology (2005)
Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
Melvyn P. Heyes;Bruce J. Brew;Alex Martin;Richard W. Price.
Annals of Neurology (1991)
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification
Gilles J. Guillemin;Gilles J. Guillemin;Bruce J. Brew.
Journal of Leukocyte Biology (2004)
Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex
Paul M Maruff;Elizabeth Thomas;Lucette A Cysique;Lucette A Cysique;Bruce J Brew.
Archives of Clinical Neuropsychology (2009)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Gilles J. Guillemin;Stephen J. Kerr;George A. Smythe;Danielle G. Smith.
Journal of Neurochemistry (2001)
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
Gregory J. Dore;Patricia K. Correll;Yueming Li;John M. Kaldor.
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
Gilles J. Guillemin;George Smythe;Osamu Takikawa;Bruce J. Brew;Bruce J. Brew.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: